Winners of
Dermatologist, Chile
+
Dermatologist, Singapore
+
Dermatologist, Egypt
+
Dermatologist, Madagascar
+
Dermatologist, Taiwan
+
Dermatologist, Germany
+
Winners of
Dermatologist, TUNISIA
+
Dermatologist, MEXICO
+
Dermatologist, BURKINA FASO
+
Dermatologist, SINGAPORE
+
Dermatologist, POLAND
+
Dermatologist, TAIWAN
+
Winners of
Dermatologist, The Netherlands
+
Dermatologist, BRAZIL
+
Dermatologist, NIGERIA
+
Dermatologist, AUSTRALIA
+
Winners of
Dermatologist, BRAZIL
+
Dermatologist, KENYA
+
Dermatologist, FRANCE
+
Dermatologist, SINGAPORE
+
Winners of
Dermatologist, SINGAPORE
+
Dermatologist, Germany
+
Dermatologist, Uruguay
+
Dermatologist,
THE NETHERLANDS
This research aims to explore the perceived QoL of patients with genodermatoses at different stages in their life (pediatric – young adult – old aged) and from the perspective of caregivers and/or families. Currently, treatment options are mostly limited to managing symptoms. The project will use a patient-centered, qualitative approach, combined with quantitative studies in order to develop group-specific questionnaires and ultimately improve personalized care.
Dermatologist, BRAZIL
The aim of the research project is to investigate the possible clinical and biological correlations between vitiligo, QoL and sleep, examining the role of phototherapy and inflammatory cytokines. by undertaking a prospective study using specific questionnaires and serum component analysis,ùn the project expects to demonstrate that phototherapy improves sleep and quality of life in vitiligo patients, potentially by influencing circadian rhythms and immune markers.
Dermatologist, NIGERIA
This research project aims to evaluate and improve the quality of life of people with albinism (PWA) in Nigeria, a country with the largest population of PWA in Africa. The major concerns of PWA include ultraviolet radiation-induced dermatoheliosis and high skin cancer risk, poor eyesight hindering education and employment opportunities, stigma and discrimination The project will assess existing quality of life and implement a six-month program combining patient education through social media, an online community platform and in-person workshops for family and teachers.
Dermatologist, AUSTRALIA
This project proposes a unique care model integrating dermatologist consultations with dedicated nurse-led patient education, aiming to empower patients and improve self-efficacy in managing their eczema. Eczema necessitates extensive patient education for effective management, however the current healthcare model struggles to provide sufficient time for this education, especially in regional areas where access to dermatologist is limited. The study will evaluate this model’s impact on patient outcomes, satisfaction, and potentially influence healthcare policy decisions.
Dermatologist, BRAZIL
The goal of this project is to conduct an online education pilot program for patients with atopic dermatitis. The program aims to improve treatment adherence, enhance patients' understanding of the disease, and assess the impact of AD on quality of life. By leveraging digital technologies, the program would provide accessible and convenient support while minimizing additional costs for patients and caregivers.
Dermatologist, KENYA
This research aims to investigate the impact of eczema on the quality of life of patients in Kenya, which has been largely unexplored in Africa. The author anticipate that the findings may contribute to the development of local treatment approaches, improved support services, and raise awareness about the need for additional dermatologists and better skincare products for eczema treatment.
Dermatologist, FRANCE
The goal of this project is to enhance the patient education program for individuals with Neurofibromatosis 1 (NF1) by introducing hybrid sessions to increase participation. The project aims to combine in-person sessions, e-learning modules, and webinars to reach a wider population, including those with mobility disabilities, work constraints, and geographical limitations. By incorporating these adaptations, the project seeks to improve the quality of life for NF1 patients.
Dermatologist, SINGAPORE
The study aims to investigate the quality of life and sun protection behavior in organ transplant recipients with skin cancer. They plan to recruit 50 transplant recipients with a history of skin cancer and evaluate their quality of life at regular intervals. The study seeks to understand the impact of education and sunscreen on quality of life in this high-risk population.
Dermatologist, SINGAPORE
Our service is mainly focusing on Psoriasis, an inflammatory skin disease that symptoms mainly with dry skin lesions. Theses plaques can be itchy or sore, that really impacts quality of life of many patients. We are happy to have been awarded 25 000 USD by La Roche-Posay Research grants. This prize will be used to support patients. In liaison with the GLOBAL PSORIASIS ATLAS, we will develop a smartphone application with 2 main objectives: study and create data around the impact of psoriasis in the daily patient’s life, and help all patients though community resources, medication counselling, or survey to track symptoms.
Dermatologist, Germany
"In my service we are focusing on patients suffering from rare skin diseases: Morbus Darier and Morbus Hailey Hailey. These pathologies terribly affect their quality of life with intense itching, pain, burning sensations. I am really happy to have been awarded 25 000€ by La Roche Posay Research grants: it will allow us to organize supportive medical events with psychologists, wound managers or surgeons to support these patients who are often forgotten and suffer a lot."
Dermatologist, Uruguay
"In women, breast cancer is by far the one with the highest incidence and mortality rate. More than 80% of cancer patients develop skin side effects related to different treatments. The widespread use of smartphones and telemedicine makes daily reports of symptoms and side effects feasible through mobile applications. We are happy to have been awarded 25 000 USD by La Roche-Posay Research grants to develop our own mobile app to generalized to all breast cancer patients. This tool, easy to apply, will generate support for cancer patients."
Dermatologist, Chile
This project focuses on atopic dermatitis (AD) and its link to periodontitis, exploring how systemic inflammation and oral health impact patients' mental well-being and quality of life. Conducting a case-control study with adults, the research evaluates periodontal pathogens, inflammatory mediators and oral health-related QoL outcomes. By identifying these modifiable biological links, the study aims to pave the way for integrated dermatological, oral and mental healthcare to improve patient well-being.
Dermatologist, Singapore
This project focuses on allergic contact dermatitis (ACD), assessing its impact on quality of life in a region still developing comprehensive consumer allergen regulations. Conducting a prospective study with 150 patients undergoing patch testing, the research combines validated quality-of-life instruments with in-depth interviews to evaluate how allergen identification and counseling improve patient outcomes over time. Ultimately, the project aims to develop educational resources, product guides and consumer databases to better support affected individuals.
Dermatologist, Egypt
This project focuses on leprosy, where deep-rooted social stigma and community misconceptions inflict profound psychosocial harm and diminish patients' quality of life. Combining medical and psychological rehabilitation with structured community awareness campaigns and healthcare worker training, the study evaluates changes in patient QoL and perceived stigma over 12 months. By treating stigma reduction as a core clinical outcome, this holistic initiative aims to improve patient well-being, reduce social isolation, and provide a replicable model for dermatological care.
Dermatologist, Madagascar
Operating in Madagascar with only 18 dermatologists for 28 million inhabitants, this project addresses atopic dermatitis, a chronic condition largely managed by families alone, resulting in poor treatment adherence for 61.90% of adults and 45.45% of children. To bridge this gap, the initiative launches EAN-Mada (Ecole de l’Atopie Numérique), a fully digital Atopy School in Malagasy and French delivered via YouTube videos and a WhatsApp chatbot. Built upon a qualitative inquiry into local practices and beliefs, a prospective controlled trial will evaluate 100 participants over 6 months. By delivering accessible therapeutic education tailored to local practices, the initiative aims to improve disease severity, treatment adherence and overall quality of life.
Dermatologist, Taiwan
This project focuses on chronic hand eczema (CHE) among healthcare workers, where frequent irritants and allergens impair quality of life, work productivity and hand-hygiene adherence. Evaluating an integrated care model combining dermatology and occupational medicine, the study delivers personalized exposure assessments, skin-protection protocols, education and digital tracking for 40 participants. By targeting the specific drivers of CHE, this pilot trial aims to restore patient QoL, sustain safe hand hygiene and keep healthcare workers safely at work.
Dermatologist, Germany
This project focuses on chronic urticaria, where severe pruritus heavily disrupts sleep, work productivity, and quality of life. The study investigates whether neutrophil-derived IL-17 drives itch through neuroimmune interactions, combining translational skin analyses with patient-reported outcomes on itch severity and disease control. By placing pruritus and quality of life at the center of investigation, this research aims to uncover novel biomarkers and therapeutic targets for treatment-refractory patients, with the potential to improve care, reduce disease burden, and enhance patients' quality of life.
Dermatologist,
Tunisia
This pilot study introduces a care model that integrates dermatology consultations with a structural protocol for allergen avoidance. This approach addresses the often-neglected role of contact sensitization, a common aggravating factor in atopic dermatitis (AD), which is often overlooked by current treatments. The study aims to determine whether it leads to enhanced clinical outcomes, improved disease management for patients, and overall, their quality of life with AD.
Dermatologist, MEXICO
This project is focused on psoriasis, a skin disease affecting around 125 million people. Its intersection with obesity aggravates inflammation and affects patients’ the quality of life. This study will be conducted with 62 participants. The goal is to evaluate whether the addition of antidiabetic medications, semaglutide or metformin, to a basic treatment with topical corticosteroid can improve skin problems and patients' quality of life. Key measures include lesion severity (PASI), patient-reported quality of life, and inflammatory biomarkers markers. This trial has the potential to reshape how psoriasis is treated globally, leading to updated clinical guidelines, enhanced patient quality of life, and a reduced global healthcare burden.
Dermatologist, BURKINA FASO
The goal of this project is to integrate a structured patient therapeutic education (TPE) program, the Atopic School, into the management of patients with atopic dermatitis (AD) in Ouagadougou by 2026, by addressing the escalating public health challenge of AD in Burkina Faso, which impacts patients’ quality of life and faces limited resources for comprehensive disease understanding. By offering continuous learning and psychosocial support, this program aims to empower patients, strengthening their knowledge and autonomy for better disease management and improved their quality of life.
Dermatologist, SINGAPORE
Autoimmune bullous diseases (AIBD) are known to significantly affect the quality of life (QoL) of both patients and their caregivers. This mixed-methods study aims to assess the QoL of 128 patients with AIBD and 128 corresponding caregivers of patients with pemphigoid and pemphigus through quantitative questionnaire analysis. In addition, qualitative data will be obtained via face-to-face interviews with 30 patients and their accompanying caregivers. By integrating these findings, the study seeks to provide a comprehensive understanding of QoL and to facilitate the design of tailored interventions to improve the QoL of both patients and caregivers.
Dermatologist, POLAND
In dermatological conditions, pruritus is often prioritized while pain is overlooked. This study aims to explore the interaction between pain and pruritus in patients with chronic dermatoses, specifically examining their co-occurrence, their impact on patient well-being, and variations across dermatological conditions. Data collection will include various clinical and patient measures. By addressing this neglected aspect of dermatological care, the study seeks to promote a more comprehensive, patient-centered approach to symptom management and improve quality of life.
Dermatologist, TAIWAN
Chronic pruritus affects 13-17% globally and has an enormous impact on the quality of life (QoL), disrupting sleep, impairing occupational performance, and increasing the risk of psychological disorders and social isolation. It also leads to heavy dependence on systemic medications with antihistamine or sedative properties. The project aims to quantify the impact of antihistamine burden, identify immune correlates of antihistamine-resistant itch, and evaluate the psychosocial effects of chronic pruritus across diverse dermatological subgroups. Through patient education, this research will also investigate how increasing awareness and promoting personalized anti-pruritic strategies can enhance patient QoL.
